Susquehanna International Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.2M Sell
78,552
-41,523
-35% -$42.1M 0.01% 1025
2025
Q4
$129M Sell
120,075
-61,943
-34% -$59.2M 0.01% 734
2025
Q3
$139M Sell
182,018
-30,027
-14% -$22.3M 0.02% 702
2025
Q2
$165M Buy
212,045
+127,705
+151% +$99.2M 0.02% 521
2025
Q1
$69.7M Sell
84,340
-397,912
-83% -$331M 0.01% 835
2024
Q4
$372M Buy
482,252
+49,973
+12% +$41.4M 0.06% 249
2024
Q3
$383M Buy
432,279
+93,399
+28% +$84M 0.07% 241
2024
Q2
$307M Buy
338,880
+115,617
+52% +$92.5M 0.06% 251
2024
Q1
$174M Sell
223,263
-109,040
-33% -$77.6M 0.03% 439
2023
Q4
$194M Sell
332,303
-7,451
-2% -$4.35M 0.04% 408
2023
Q3
$182M Sell
339,754
-67,026
-16% -$34.5M 0.04% 373
2023
Q2
$191M Sell
406,780
-37,992
-9% -$15.9M 0.04% 359
2023
Q1
$153M Buy
444,772
+150,633
+51% +$50.8M 0.03% 445
2022
Q4
$108M Buy
294,139
+244,419
+492% +$86.7M 0.03% 518
2022
Q3
$16.1M Sell
49,720
-188,991
-79% -$59.9M ﹤0.01% 1622
2022
Q2
$77.4M Buy
238,711
+46,627
+24% +$14M 0.02% 626
2022
Q1
$55M Sell
192,084
-5,069
-3% -$1.3M 0.01% 958
2021
Q4
$54.5M Sell
197,153
-226,629
-53% -$57.5M 0.01% 1040
2021
Q3
$97.9M Buy
423,782
+107,171
+34% +$26.5M 0.01% 790
2021
Q2
$72.7M Sell
316,611
-33,251
-10% -$6.68M 0.01% 949
2021
Q1
$65.4M Buy
349,862
+228,755
+189% +$44.7M 0.01% 934
2020
Q4
$20.4M Sell
121,107
-38,103
-24% -$5.69M ﹤0.01% 1715
2020
Q3
$23.6M Buy
159,210
+35,516
+29% +$5.5M ﹤0.01% 1346
2020
Q2
$20.3M Buy
123,694
+80,442
+186% +$12.3M ﹤0.01% 1413
2020
Q1
$6M Sell
43,252
-196,684
-82% -$27M ﹤0.01% 2344
2019
Q4
$31.5M Buy
239,936
+212,073
+761% +$24.6M 0.01% 1089
2019
Q3
$3.12M Buy
27,863
+15,744
+130% +$1.75M ﹤0.01% 3422
2019
Q2
$1.34M Buy
12,119
+8,918
+279% +$1.05M ﹤0.01% 5018
2019
Q1
$415K Buy
+3,201
New +$389K ﹤0.01% 6627
2018
Q3
Sell
-14,257
Closed -$1.43M 9793
2018
Q2
$1.22M Buy
14,257
+1,063
+8% +$87.3K ﹤0.01% 4937
2018
Q1
$1.02M Sell
13,194
-3,006
-19% -$242K ﹤0.01% 5198
2017
Q4
$1.37M Buy
+16,200
New +$1.38M ﹤0.01% 4616
2017
Q2
Sell
-23,800
Closed -$1.94M 9542
2017
Q1
$2M Sell
23,800
-850,895
-97% -$68.2M ﹤0.01% 3721
2016
Q4
$64.3M Buy
874,695
+741,678
+558% +$55.2M 0.03% 468
2016
Q3
$10.7M Buy
133,017
+128,450
+2,813% +$10.3M 0.01% 1483
2016
Q2
$360K Sell
4,567
-488,863
-99% -$36.8M ﹤0.01% 6667
2016
Q1
$35.5M Buy
493,430
+97,903
+25% +$7.41M 0.02% 671
2015
Q4
$33.3M Sell
395,527
-168,703
-30% -$14M 0.02% 809
2015
Q3
$47.2M Buy
564,230
+431,358
+325% +$36.4M 0.02% 657
2015
Q2
$11.1M Sell
132,872
-18,769
-12% -$1.43M ﹤0.01% 1884
2015
Q1
$11M Sell
151,641
-49,873
-25% -$3.55M 0.01% 1781
2014
Q4
$13.9M Sell
201,514
-133,806
-40% -$9.03M 0.01% 1669
2014
Q3
$21.7M Sell
335,320
-24,451
-7% -$1.55M 0.01% 1334
2014
Q2
$22.4M Buy
359,771
+123,826
+52% +$7.39M 0.01% 1297
2014
Q1
$13.9M Sell
235,945
-14,793
-6% -$826K 0.01% 1642
2013
Q4
$12.8M Sell
250,738
-148,843
-37% -$7.45M 0.01% 1778
2013
Q3
$20.1M Sell
399,581
-237,495
-37% -$12.4M 0.01% 1204
2013
Q2
$31.3M Buy
+637,076
New +$34.7M 0.02% 800

Other funds holding LLY

Susquehanna International Group's LLY Position: Q1 2026 in Review

Susquehanna International Group reduced its Eli Lilly (LLY) stake by 35% in Q1 2026, selling an estimated $42.1M and leaving 78,552 shares worth $72.2M. The position accounts for 0.01% of the portfolio, ranked #1025.

Susquehanna International Group first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $383M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Susquehanna International Group held 78,552 shares of Eli Lilly worth $72.2M as of Q1 2026.
  • Susquehanna International Group sold 41,523 Eli Lilly shares in Q1 2026, an estimated $42.1M.
  • Eli Lilly made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1025 holding.
  • Susquehanna International Group first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Eli Lilly position peaked at $383M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.